Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Amarin Corp ADR (AMRN)

Amarin Corp ADR (AMRN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 563,088
  • Shares Outstanding, K 396,541
  • Annual Sales, $ 583,190 K
  • Annual Income, $ 7,730 K
  • 60-Month Beta 2.08
  • Price/Sales 0.98
  • Price/Cash Flow 23.50
  • Price/Book 0.89
Trade AMRN with:

Options Overview Details

View History
  • Implied Volatility 320.28% ( +113.57%)
  • Historical Volatility 184.19%
  • IV Percentile 98%
  • IV Rank 58.52%
  • IV High 516.47% on 05/05/22
  • IV Low 43.48% on 11/03/21
  • Put/Call Vol Ratio 0.17
  • Today's Volume 780
  • Volume Avg (30-Day) 2,174
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 135,131
  • Open Int (30-Day) 129,293

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.06
  • Number of Estimates 5
  • High Estimate -0.03
  • Low Estimate -0.10
  • Prior Year 0.02
  • Growth Rate Est. (year over year) -400.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1100 +27.93%
on 05/12/22
3.2350 -56.11%
on 04/21/22
-1.7400 (-55.06%)
since 04/20/22
3-Month
1.1100 +27.93%
on 05/12/22
3.7400 -62.03%
on 04/06/22
-1.8900 (-57.10%)
since 02/18/22
52-Week
1.1100 +27.93%
on 05/12/22
5.9700 -76.21%
on 08/23/21
-3.1500 (-68.93%)
since 05/20/21

Most Recent Stories

More News
Amarin Announces Appointment of New Directors and Board Leadership Changes

Erin Enright and Alfonso “Chito” Zulueta Appointed to Board of Directors New Board Members Bring Skills and Experience Aligned with the Company’s...

AMRN : 1.4200 (-1.39%)
New Strong Sell Stocks for May 13th

DDD, AMRN, and BDX have been added to the Zacks Rank #5 (Strong Sell) List on May 13, 2022.

BDX : 252.30 (+0.46%)
DDD : 10.40 (-0.57%)
AMRN : 1.4200 (-1.39%)
Amarin to Present at Two Upcoming Investor Conferences

DUBLIN, Ireland and BRIDGEWATER, N.J., May 12, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Karim Mikhail, Amarin’s...

AMRN : 1.4200 (-1.39%)
Amarin (AMRN) Q1 Earnings & Sales Hurt by Vascepa Generics

Amarin's (AMRN) Vascepa sales decline year over year amid rising generic competition and COVID-related disruptions during the first quarter. The company's stock falls significantly on May 4.

ALKS : 30.00 (+1.76%)
AMRN : 1.4200 (-1.39%)
BGNE : 137.32 (+4.29%)
DCPH : 11.84 (+4.13%)
Amarin (AMRN) Q1 2022 Earnings Call Transcript

AMRN earnings call for the period ending March 31, 2022.

AMRN : 1.4200 (-1.39%)
Why Amarin Stock Is Sinking on Wednesday

Missed expectations on the top and bottom lines suggest Amarin's path forward isn't as clear as investors want it to be.

AMRN : 1.4200 (-1.39%)
Amarin Reports First Quarter 2022 Financial Results and Provides Business Update

 Initiated Next Phase of European Expansion Strategy with First National Reimbursement in Sweden Market Access Negotiations and Launch Preparations for...

AMRN : 1.4200 (-1.39%)
Amarin Partner HLS Therapeutics Completes Reimbursement Negotiations with Pan-Canadian Pharmaceutical Alliance (pCPA) for VASCEPA® (icosapent ethyl)

DUBLIN, Ireland and BRIDGEWATER, N.J., April 26, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) announced today its partner HLS...

AMRN : 1.4200 (-1.39%)
Amarin to Report First Quarter 2022 Financial Results and Host Conference Call On May 4, 2022

DUBLIN, Ireland and BRIDGEWATER, N.J., April 19, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a...

AMRN : 1.4200 (-1.39%)
Eicosapentaenoic Acid (EPA) Combined with Widely Used Statins Significantly Reduced Lipid Oxidation in Model Membranes

Experimental trial research presented at the American College of Cardiology’s 71st Annual Scientific Session showed that the combinations of...

AMRN : 1.4200 (-1.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Amarin Corporation plc is a commercial-stage pharmaceutical company focused on developing therapies, especially based on omega-3 fatty acid for treating cardiovascular diseases. The company's sole marketed drug, Vascepa (icosapent ethyl) is approved in the United States as an adjunct to diet for treating...

See More

Key Turning Points

3rd Resistance Point 1.6467
2nd Resistance Point 1.5733
1st Resistance Point 1.4967
Last Price 1.4200
1st Support Level 1.3467
2nd Support Level 1.2733
3rd Support Level 1.1967

See More

52-Week High 5.9700
Fibonacci 61.8% 4.1135
Fibonacci 50% 3.5400
Fibonacci 38.2% 2.9665
Last Price 1.4200
52-Week Low 1.1100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar